Comparative analysis of pain in patients who underwent total knee replacement regarding the tourniquet pressure  by de Souza Leão, Marcos George et al.
r e v b r a s o r t o p . 2 0 1 6;5 1(6):672–679




Comparative  analysis  of  pain  in  patients  who
underwent total  knee  replacement  regarding  the
tourniquet pressure
Marcos George de Souza Leão ∗, Gladys Pedrosa Martins Neta,
Lucas  Inoue Coutinho, Thiago Montenegro da Silva,
Yacov Machado Costa Ferreira, Waryla Raissa Vasconcelos Dias
Fundac¸ão Hospital Adriano Jorge, Manaus, AM,  Brazil
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 16 October 2015
Accepted 10 February 2016





a  b  s  t  r  a  c  t
Objectives: To evaluate through the visual analog scale (VAS) the pain in patients undergoing
total knee replacement (TKR) with different pressures of the pneumatic tourniquet.
Methods: An observational, randomized, descriptive study on an analytical basis, with 60
patients who underwent TKR, divided into two groups, which were matched: a group where
TKR  was performed with tourniquet pressures of 350 mmHg (standard) and the other with
systolic blood pressure plus 100 mmHg (P + 100). These patients had their pain assessed by
VAS  at 48 h, and at the 5th and 15th days after procedure. Secondarily, the following were
also measured: range of motion (ROM), complications, and blood drainage volume in each
group; the data were subjected to statistical analysis.
Results: After data analysis, there was no statistical difference regarding the incidence of
complications (p = 0.612), ROM (p = 0.202), bleeding after 24 and 48 h (p = 0.432 and p = 0.254)
or  in relation to VAS. No correlation was observed between time of ischemia compared to
VAS  and bleeding.
Conclusions: The use of the pneumatic tourniquet pressure at 350 mmHg or systolic blood
pressure plus 100 mmHg did not inﬂuence the pain, blood loss, ROM, and complications.
Therefore the pressures at these levels are safe and do not change the surgery outcomes;
the  time of ischemia must be closely observed to avoid major complications.©  2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Ortopedia
e  Traumatologia. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
 Study conducted at the Fundac¸ão Hospital Adriano Jorge, Departamento de Ortopedia e Traumatologia, Manaus, AM,  Brazil.
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2255-4971/© 2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Ortopedia e Traumatologia. This is an open
access  article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Análise  comparativa  da  dor  em  pacientes  submetidos  à  artroplastia  total





r  e  s  u  m  o
Objetivos: Avaliar, por meio da escala visual analógica (EVA), a dor em pacientes submetidos
à  artroplastia total do joelho (ATJ) com diferentes pressões do torniquete pneumático.
Métodos: Foi feito um estudo observacional, descritivo, de caráter analítico, prospectivo,
randomizado, no qual 60 pacientes foram submetidos à ATJ, divididos em dois grupos, os
quais  foram comparados entre si: um grupo no qual a ATJ foi feita com pressão do torniquete
de  350 mmHg (Padrão) e outro com 100 mmHg acima da pressão arterial sistólica (P + 100).
Esses pacientes tiveram sua dor aferida pela EVA após 48 horas, no quinto e no 15◦ dias
após  o procedimento cirúrgico. Secundariamente, foram medidos também a amplitude de
movimento (ADM), o sangramento via dreno suctor e as complicac¸ões em cada um dos
grupos estudados; os dados foram submetidos à análise estatística.
Resultados: Após a análise dos dados, não foi constatada diferenc¸a estatisticamente signif-
icante em nível de 5% de signiﬁcância da pressão em relac¸ão à incidência de complicac¸ões
(p  = 0,612), ADM (p = 0,202), ao sangramento após 24 e 48 h (p = 0,432 e p = 0,254) e à EVA.
Também não foi constatada correlac¸ão do tempo de isquemia em relac¸ão a EVA e ao san-
gramento.
Conclusões: As pressões usadas do torniquete pneumático, 350 mmHg ou pressão arterial
sistólica + 100 mmHg, não tiveram inﬂuência sobre a dor, a perda sanguínea, a amplitude
de  movimento e as complicac¸ões, são pressões seguras que não alteram o resultado ﬁnal,
desde que respeitados o tempo da isquemia e individualizados os casos.
©  2016 Publicado por Elsevier Editora Ltda. em nome de Sociedade Brasileira de




























Fig. 1 – Tourniquet used by the Romans. The tourniquet is
made of bronze and is covered with leather to help protect
the thigh of the patient and reduce pain.
Source: Printed with permission of the Science and Societyntroduction
he role of the pneumatic tourniquet is still controversial.
owever, it is widely used by orthopedic surgeons. It is
elieved that its use is effective in reducing intraoperative
lood loss and creating a bloodless ﬁeld, which would theoret-
cally facilitate surgery and the cementation technique. The
se of the tourniquet is almost indispensable in orthopedic
ractice.
The modern pneumatic tourniquet has its roots in Roman
imes (199 BC to 500 AD), when bronze and leather devices
Fig. 1) were used to control bleeding in limb amputations dur-
ng battles. The term tourniquet was coined by Jean Louis Petit,
eing a derivation of the French verb tourner (rotate). With the
dvent of general anesthesia, in 1864 Joseph Lister was the
rst to use a tourniquet to create a bloodless surgical ﬁeld.
n 1904, Harvey Cushing introduced the ﬁrst inﬂatable (pneu-
atic) cuff, thus allowing the pressure of the tourniquet to be
onitored and controlled manually.1
A disadvantage of the tourniquet is the morbidity that
omes from its use, especially in neuromuscular injuries
econdary to neural and muscle tissues ischemia and to nerve-
ompressing direct injury. Furthermore, the hemodynamic
hanges that accompany inﬂation and deﬂation may depress
ardiac function in the perioperative period.2 The duration
nd pressure for safe tourniquet use remain controversial,
nd no strict guidelines have been established. A safe limit
f 1–3 h has been described.3 The use of the tourniquet over
 h and pressures greater than 350 mmHg  on the lower limbsPicture Library: http://www.scienceandsociety.co.uk/.
and greater than 250 mmHg  on the upper limbs increase the
risk of compression and neuropraxia.4
The most common way to assess pain is through the visual
analog scale (VAS), an instrument that attempts to measure a
characteristic or attitude that is believed to vary over a con-
tinuum of values and that cannot be directly measured easily.
For example, the amount of pain the patient feels may range
5from no pain (0) to extreme pain (10).
The aim of this study was to assess, through VAS, the
pain in patients undergoing TKA. Two groups of patients
were compared: in the ﬁrst group, TKA was performed with
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Assessed for eligibility (n=71)
Exclusion (n=11)
♦ Did not meet inclusion criteria (n=9)
♦ Refused to participate (n=0)
♦ Other reasons (n=2) 
Analyzed   (n=30)
♦ Exclusion Ø
Loss to follow-up Ø
Group P+100 mmHg (n=30)
♦ Received intervention (n=30)
Loss to follow-up Ø
Group 350 mmHg (n=30)








Fig. 2 – CONSORT ﬂowchart.tourniquet pressures of 350 mmHg, and in the other group,
with 100 mmHg  above systolic blood pressure (SBP). Sec-
ondarily, blood loss, surgical wound complications, and the
range of motion (ROM) of the operated knee were assessed.
Thereafter, the safer and more  advantageous method for the
patients was determined.
Materials  and  methods
This was a randomized clinical study; the main investiga-
tor was blinded to the pressure that would be used in the
tourniquet. This study was conducted from September 2014 to
September 2015, including 60 patients undergoing TKA. The
study followed the rules set forth by the Consolidated Stan-
dards of Testing Reports (CONSORT, which was developed by
an international group of clinical, statisticians, epidemiolo-
gists, and biomedical journals publishers in order to improve
the recording of randomized clinical trials and thus allow read-
ers to understand the study design, behavior analysis, and
interpretation through full transparency) (Fig. 2).6,7
A protocol was created for the study. Patients who met  eli-
gibility criteria for TKA in this study were randomly assigned,
regardless of age, sex, and deformity, into two groups, through
simple drawing by one of the authors, who did not par-
ticipate in surgery. In the ﬁrst group, Standard, tourniquet
pressure on the thigh root was 350 mmHg; in the second
group, P + 100, utilizing tourniquet pressures 100 mmHg  abovethe last SBP measured before entering the operating room
(process done in the recovery room). The groups were ran-
domized as follows: 60 Post-it®(3 M do Brasil, Sumaré, SP)
sheets, 101 mm × 101 mm,  of the same color, were used. On
30 of them, the word “Standard” was written; on the other 30,
“P + 100.” The sheets were twice folded and placed into a cloth
bag. Then, sheets were drawn as the patients were operated;
if the surgery was suspended for any reason, sheets would
be returned to the bag. Thus, the Standard group consisted
of 30 patients, seven males and 23 females, mean 65.4 years,
standard deviation (SD) ± 8.6 years. In the group P + 100, 30
patients were included, eight male and 22 female, with a mean
age of 66 years (SD ± 7 years). Varus deformity was present in
83.3% of cases; valgus deformity was observed in 16.7% of all
patients.
The study included patients regularly registered in the
institution where the study was performed, who  met  the
classical indication for TKR, namely: medial or lateral
impingement with obliteration of the joint space; varus
femorotibial alignment greater than 15◦; valgus femorotib-
ial alignment greater than 10◦; tibiofemoral subluxation in
the frontal plane greater than 10 mm;  anteriorization of the
tibia relative to the femur in the proﬁle X-ray; severe impair-
ment of two  of the three joint compartments of the knee
8(medial tibiofemoral, lateral tibiofemoral, or patellofemoral),
and failed conservative treatment for at least three months
when these criteria were not met. Although the consensus
states that the preferable age for this surgery is above 60 years,
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Table 1 – Bruner’s ten rules for the safe use of the
tourniquet (as recommended by Kutty and McElwain).11
Application Only in healthy limbs, or with caution in
involved limbs.
Size of the tourniquet Arm 10 cm; thigh 15 cm or larger in larger
thighs.
Application site Proximal arm; proximal thigh.
Padding At least two layers of orthopedic cotton.
Skin preparation Avoid soaking the cotton (the tourniquet
should be occluded).
Pressure 50–100 mmHg above systolic for the arm;
double systolic for the thigh; or
200–250 mmHg on the arm;
250–350 mmHg on the thigh.
Time (duration) Maximum 3 h (recovers in 5–7 days);
generally, do not exceed 3 h.
Temperature Avoid heating; cold if feasible; the surgical
ﬁeld should be kept moist.
Documentation Duration and pressure.






































Visual analogue scale – VAS
Intense
The right side was operated in 53.3% of cases; the left side,Maintenance Quarterly.
ge was not taken into account, but rather the real damage to
he knee joint: patients had to have a diagnosis of moderate
r more  severe arthrosis (Ählback modiﬁed by Keys ≥ III).9,10
Exclusion criteria comprised patients with decompensated
iabetes mellitus (fasting blood glucose > 140 mg/dL), uncon-
rolled hypertension (SBP > 200 mmHg), peripheral vascular
isease, previous thromboembolism, active neoplasia, infec-
ion, rheumatoid arthritis, obese with a body mass index
reater than 35 kg/m2, or those with a high surgical risk (Amer-
can Society of Anesthesiologists [ASA] score > III); those who
volved with severe complications; and those who refused to
ign or did not understand the informed consent form.
For the application of tourniquet, Bruner’s ten rules for
he safe use of the tourniquet (a recommended by Kutty and
cElwain), shown in Table 1, were followed.11 The tourniquet
sed in all patients was a 12.5-cm wide Scandmed Electronic
ourniquet 600-20® (Scandmed AB, Stockholm, Sweden).
Patients underwent spinal anesthesia according to the
rotocols of the anesthesiology service of the institution
anesthesiologists were blinded to the purpose of the study).
fter anesthesia, the pneumatic tourniquet was applied on
he thigh root of the limb to be operated over a layer of ortho-
edic cotton, in order to protect the skin. Surgical technique
sed was the standard for TKR, with joint access via the classic
rans-quadriceps approach and patellar eversion. The routine
n the service is the use of intramedullary guides for femoral
uts and extramedullary guides for tibial cuts. The decision
f whether or not to spare the posterior cruciate ligament
PCL) was made in accordance with the intraoperative ﬁnd-
ngs, deformities, and soft tissue balance. Patellar resurfacing
fter local denervation and synovectomy is a routine practice
n this service in order to avoid clunk syndrome; the cases in
hich the patella was not resurfaced were due to the thick-
ess (<18 mm),  but these were eburnated, neurotized, and a
ateral facetectomy was performed. The prosthesis used was
he Modular III® (MDT, Rio Claro, SP, Brazil), either PCL-sparing
r not. Portovac suction drains of 3.2-mm diameter were used,
llocated intraarticularly and deeply into the subcutaneousFig. 3 – Visual analog scale (VAS).
tissue; after the sutures, an inguinal-malleolar compressive
occlusive Robert Jones dressing was made. If surgery lasted
over two hours, the tourniquet was deﬂated; subsequently,
hemostasis was assessed, and a process similar to the pre-
vious was performed (drains and dressings). Mean time of
ischemia was 118.5 min  in group P + 100 mmHg  and 110 min
in the Standard group. Surgeries were always performed by
the principal investigator or under his direct assistance.
At 24 and 48 h postoperatively, the outputs of the suc-
tion drains were assessed; dressings were changed and drains
were removed 48 h after the procedure by the author who
did not draw the groups. Subsequently, pain was assessed
using the VAS (Fig. 3) with no joint manipulation; passive
ROM and the surgical wound were assessed. According to
their clinical conditions, patients received the same analge-
sia protocol (tenoxicam 20 mg  every 12 h, tramadol 50 mg  IV
every 8 h, dipyrone 1 g IV every 6 h), and rehabilitation. On
the ﬁfth day, patients were assessed again for pain, ROM, and
surgical wound appearance; they were discharged as toler-
ated and referred to the physiotherapy service. On the 15th
day, these standards were re-assessed in an outpatient con-
sultation and recorded in the protocol. All patients received
thromboprophylaxis with dabigatran at a dose adjusted to
age and renal function for 15 days (220 mg  or 15 mg/day). All
patients received prophylaxis for surgical site infection with
cefazolin sodium at a dose of 1 g every 8 h for ﬁve days.
The data were presented in graphs and tables, in which the
simple and relative absolute frequencies were calculated for
categorical data. In the analysis of quantitative data, the mean,
standard deviation (SD), and 95% conﬁdence intervals (95% CI)
were calculated. However, when the assumption of data nor-
mality was rejected by the Shapiro–Wilk test at a signiﬁcance
level of 5% (p < 0.05), it was decided to calculate the median and
quartiles (Qi). When comparing the means for the parametric
data, Student’s t-test was used. In the median analysis, the
nonparametric Mann–Whitney test was used. The signiﬁcance
level was set at 5%.
Epi-Info software, version 7.4 for Windows, was used for
statistical analysis.
All patients read and signed the informed consent form;
the study was submitted to the Research Ethics Commit-
tee (REC) of the institution, with a Certiﬁcate of Presentation
for Ethical Assessment (CAAE): 36658014.2.0000.0007, and
received REC opinion No. 869.472.
Results
Of the 60 patients operated, 45 were female and 25 male.46.7%. There was a predominance of varus deformity, with 50
patients; only ten patients had valgus deformity. There was
one complication on group P + 100 mmHg  and three in the
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Table 2 – Summary of patient assessments.
Tourniquet pressure (mmHg)
Variables (n = 60) P + 100 350
fi % fi % Total p
Sex 0.766a
Female 22 48.9 23 51.1 45
Male 8 53.3 7 46.7 15
Age (years) 0.794b
Mean ± SD 66.0  ± 7.0 65.4  ± 8.6
Complications 0.612c
Yes 1 3.3 3 10.0 4
No 29 96.7 27 90 56
VAS 2nd POD 0.625d
Median 2.0 2.0
Q1–Q3 0.5–3.0 0.5–4.0
VAS 5th POD 0.571d
Median 2.0 1.0
Q1–Q3 1.5–3.0 0.5–3.0
VAS 15th POD 0.195d
Median 2.0 3.0
Q1–Q3 1.0–3.0 1.5–5.0
Bleeding 24 h 0.432d
Median 525.0 590.0
Q1–Q3 380–760 450–900
Bleeding 48 h 0.254d
Median 170.0 120.0
Q1–Q3 105–240 55–180
fi, simple absolute frequency; SD: standard deviation; Qi, quartile; VAS, visual analog scale; TKA, total knee arthroplasty.
a Pearson’s chi-squared test.
b Student’s t-test.
c Fisher’s exact test.
d Mann–Whitney test.
Standard group, with no statistically signiﬁcant difference
(p = 0.612). The VAS in the second, ﬁfth, and 15th postoperative
days (POD) also showed no statistically signiﬁcant differences
(p = 0.625; 0.571; 0.195; respectively). Bleeding through the
suction drain at 24 and 48 h also showed no statistically
signiﬁcant differences in both groups, as calculated by the
Mann–Whitney test (Table 2). The VAS and bleeding results
are better represented in the box plots in Figs. 4 and 5, respec-
tively. ROM was not signiﬁcantly different in both groups
(Table 3). No correlation was observed between ischemia time
Table 3 – Distribution according to the median of ﬂexion, exten
undergoing TKA.
Tourniq
Variables (n = 60) P + 100 mmHg 
Q1 Median Q3
Flexion pre- 100.0 110.0 120.0 
Flexion post- 90.0 95.0 100.0 
Extension pre- 0.0 2.5 10.0 
Extension post- 0.0 0.0 0.0 
ROM pre- 95.0 107.5 120.0 
ROM post 90.0 95.0 100.0 
p-Value in bold italics indicates statistical difference of the medians at 5%
fi, simple absolute frequency; Qi, quartile; ROM, range of motion; TKA, tota
a Mann–Whitney test.and the following variables: VAS on the second, ﬁfth, and
15th POD, and bleeding at 24 and 48 h (Table 4), showing no
statistical signiﬁcance.
DiscussionThe history of a surgical specialty is largely written around
the records of its technical advances. Compared with other
paraphernalia in the modern surgical arsenal, the pneumatic
sion, and ROM regarding tourniquet pressure in patients
uet pressure
350 mmHg
Q1 Median Q3 pa
100.0 110.0 120.0 0.375
90.0 97.5 130.0 0.664
0.0 0.0 10.0 0.980
0.0 5.0 10.0 <0.001
90.0 100.0 120.0 0.398
80.0 90.0 100.0 0.202
 signiﬁcance level.
l knee arthroplasty.

































Fig. 4 – Box plot of the median VAS in relation to tourniquet
pressure in patients undergoing TKA. VAS, visual analog















Fig. 5 – Box plot of the median bleeding (24 and 48 h) in







tKA, total knee arthroplasty.
ourniquet is a simple instrument. However, it has played
n important role in improving the accuracy of orthopedic
urgery. Despite being a relatively simple device, the tourni-
uet leads to many  potential dangers and its application
hould be entrusted only to experienced professionals.12
In 1995, Abdel-Salam and Eyres13 stated that the complica-
ions rate in TKAs without the use of a tourniquet was lower
Table 4 – Correlation of ischemia and VAS 2nd POD, VAS
5th POD, VAS 15th POD, and bleeding.
Ischemia time
Variables (n = 60) R pa
VAS 2nd POD −0.18 0.174
VAS 5th POD 0.21 0.102
VAS 15th POD 0.13 0.318
Bleeding 24 h −0.02 0.882
Bleeding 48 h −0.08 0.558
R, correlation coefﬁcient; VAS, visual analog scale; POD, postopera-
tive day.
a t-Test for correlation.;5 1(6):672–679 677
than when surgery utilized ischemia, in which there was a
signiﬁcant reduction in postoperative pain and faster knee
recovery. The non-use of a tourniquet in TKA showed no ben-
eﬁt, except a slightly faster recovery from postoperative pain.
When using a tourniquet in this surgery, surgeons should
carefully consider its efﬁcacy and safety. Inﬂating the tourni-
quet only during cementation or for a limited time might be
an option. Further well-designed randomized controlled tri-
als are needed to clarify the roles and compare the effects of
different methods of tourniquet application in TKAs.14
Worland et al.15 reached similar conclusions, but with a dif-
ferent method than that of the present study; those authors
recommended the use of the tourniquet with a pressure of
100 mmHg  above the systolic blood pressure for TKA, which
was suitable for creating a bloodless surgical ﬁeld and resulted
in less post-operative pain, data that are supported by the
present study.
In 2012, Tai et al.,16 in a prospective, randomized, well-
controlled study, concluded that the use of the tourniquet
in TKA reduces surgical time and blood loss; it also prevents
inﬂammation and excessive muscle damage.
The great current controversy is about whether or not to
use the tourniquet. In a recent meta-analysis, Nikolaou et al.17
concluded that the answer to this dilemma is still difﬁcult,
despite the extensive research on the subject. Clearly, several
issues concerning the use of a tourniquet arise; they relate, for
example, the best time to release the pressure and the opti-
mal  phases of the surgery for its inﬂation. In a meta-analysis,
Zhang et al.18 showed that the non-use of a tourniquet in TKA
improved clinical outcomes regarding the incidence of com-
plications and ROM in the immediate postoperative period. In
the present study, there was no signiﬁcant difference between
groups regarding the actual blood loss. Therefore, the efﬁcacy
and safety of use of the tourniquet in TKA needs to be con-
sidered, and surgeons should use it prudently. However, the
data assessed in the present study did not disclose differences
regarding blood loss.
Complications have always been present with the use of
tourniquets. Odinsson and Finsen19 observed a complication
rate similar to that of the 1970s. Castropil et al.20 reported
a case of femoral nerve injury in which the pressure of the
tourniquet was within the indicated range, and it had not
been re-inﬂated. This demonstrates that even when all the
inﬂation parameters described as suitable for knee surgery
are followed, there is still a risk for complications. Numeri-
cally, the group in which the pressure of the tourniquet was
350 mmHg  presented more  complications, but without statis-
tical signiﬁcance (p = 0.612).
Olivecrona et al.21 used a technique called “occlusion pres-
sure of the limb” and standard pressure, which may help
surgeons to individualize the cuff pressures, often lower.
They concluded that, even in the group of patients in which
the “occlusion pressure of the limb” was used, which was
generally lower, no reduction in postoperative pain or other
results was observed. However, patients undergoing TKA with
a tourniquet pressure ≤225 mmHg  had a lower rate of surgical
wound complications, such as delayed healing and infection,
ﬁndings that were reproduced in the present study, as no dif-
ferences were observed in the patterns of pain, bleeding, and
complications between the groups.
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Noordin et al.1 and Sharma and Salhotra4 gave an excel-
lent explanation about the use of tourniquets, with future
guidelines, and summarized that higher pressures on the
tourniquet are associated with a higher associated risk of
nerve damage. Ishii and Matsuda22 recommended a pressure
of 100 mmHg  above systolic pressure, instead of the conven-
tional 350 mmHg, in order to obtain a sufﬁciently bloodless
surgical ﬁeld and minimize potential complications, facts that
were observed in the study, in which surgery was perfectly fea-
sible with lower pressures and there was a general perception
of faster recovery with no evidence of major bleeding.
Souza Leão et al.,23 in a national publication, assessed
only the blood loss with the release of the tourniquet after
cementation or preparation of dressings, without taking into
account the insufﬂation pressure. They concluded that there
were no statistically signiﬁcant differences regarding hema-
timetric levels and blood loss from the suction drain; when
different cuff pressures were compared, there was no differ-
ence in blood loss, as demonstrated in the present study.
Wakankar et al.24 concluded that the use of the tourni-
quet is safe and that the practice can be maintained. There
was no signiﬁcant difference in operative time, postoperative
pain, need for analgesia, volume collected in the drains, post-
operative edema, and incidence of wound complications or
deep vein thrombosis; similar results in the evaluated param-
eters were observed in the present study. It is surgical skill
that considerably reduces surgical time and consequently the
tourniquet use; furthermore, lower complication rates are
observed.
Unver et al.25 showed that the application of the tourniquet
with lower inﬂation pressure can minimize the complications
of its use and that patients regain functional mobility faster.
Their data was corroborated by Papalia et al.,26 who indicated
that the use of the tourniquet does not lead to a signiﬁcant
increase in the risk of major complications, but with no clinical
difference in the medium-term results.
The VAS is a valid instrument for measuring pain at a spe-
ciﬁc point in time. However, pain in VAS is not linear, and
receptivity can vary depending on the peculiarities of pain.
Consequently, minimally important clinical differences either
alter the scores in general or overestimate the true change.27
Limiting factors of the present study include the short
patient follow-up after surgery, even to assess other compli-
cations such as deep vein thrombosis, which usually appears
within 30 days, but the patients were no longer entered in
the study protocol; and the absence of muscle strength tests,
as assessing the real damage caused by the tourniquet, joint
function, and the result of the surgery through speciﬁc scores
for this purpose were not among the study objectives. Finally,
it may be occasionally difﬁcult to assess pain using the VAS,
as patients may have difﬁculty understanding where to locate
themselves in order to quantify their pain.
ConclusionsWith the present data, no differences were observed in the
groups studied regarding level of pain by VAS, the volume
of bleeding through the suction drain, and knee ROM; it
was also not possible to correlate these variables with the
11 6;5 1(6):672–679
ischemia time. The complication rate was numerically higher
in the group in which the pressure of the pneumatic tourni-
quet was 350 mmHg, but without statistical signiﬁcance. Thus,
pressures of up to 350 mmHg  in the tourniquet are safe; if the
surgeon chooses to use lower pressures, these will not hin-
der the surgery nor generate any major bleeding. Pressures
should be individualized for patients; complications are much
more  related to surgeon’s experience than to the tourniquet
pressures used, as long as the appropriate parameters are fol-
lowed.
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